Manufacturing License Agreement Template

In plain language: Defines exactly what rights are being granted — to manufacture, have manufactured, use, and sell — and specifies whether the license is exclusive or non-exclusive.

Common mistake: Using 'make and sell' without specifying 'have manufactured' — omitting this means the licensee cannot legally engage subcontractors to assist in production.

In plain language: Limits where and in what application the licensee may use the licensed rights, preventing unauthorized geographic or market expansion.

Common mistake: Leaving territory undefined or writing 'worldwide' without a corresponding minimum royalty. An uncapped worldwide exclusive with no minimum gives the licensee the right to sit on the IP indefinitely.

In plain language: Sets the royalty rate or per-unit fee, establishes a minimum periodic payment, and requires the licensee to submit periodic royalty reports with supporting sales or production data.

Common mistake: Failing to define 'Net Sales' — deductions for freight, returns, and discounts can differ by 15–30% depending on how the term is constructed, directly affecting royalty income.

In plain language: Requires the licensee to manufacture products according to the licensor's specifications, grants the licensor the right to approve product samples, and establishes a corrective action process for non-conforming goods.

Common mistake: Omitting a sample approval process before full production runs. Without pre-production approval rights, the licensor has no practical leverage to enforce quality standards until substandard goods are already in the market.

In plain language: Gives the licensor the right to audit the licensee's production and financial records to verify royalty calculations, with rules on frequency, notice, and cost-sharing.

Common mistake: No audit right at all, or a provision requiring 90 days' advance notice. Without meaningful audit rights, royalty underpayment goes unchecked — and underpayment of 10–20% is common in manufacturing arrangements without regular audits.

In plain language: Confirms that the licensor retains ownership of all licensed IP, requires the licensee to mark products with appropriate patent or trademark notices, and obligates the licensee to notify the licensor of known infringement by third parties.

Common mistake: No product marking requirement. Unmarked products may weaken the licensor's patent enforcement position and, in the US, can limit recovery of damages for patent infringement.

In plain language: Addresses who owns modifications or enhancements developed by the licensee during the agreement, and whether those improvements are licensed back to the licensor.

Common mistake: Granting the licensor ownership of all improvements without compensation. Licensees who invest in product development and are required to assign improvements without consideration have little incentive to innovate — and may challenge the clause.

In plain language: Prevents the licensee from disclosing the licensor's trade secrets, formulas, technical know-how, and proprietary manufacturing processes to third parties.

Common mistake: No post-termination confidentiality tail. Without a survival clause, confidentiality obligations expire with the agreement — leaving trade secrets unprotected the day the contract ends.

In plain language: Sets the initial term, renewal conditions, and the events that allow either party to terminate early — including material breach, insolvency, or failure to meet minimum royalties.

Common mistake: Automatic renewal with no notice period. A licensee that misses a notice deadline can be locked into another full term with unfavorable economics.

In plain language: Each party warrants its authority to enter the agreement; the licensor warrants ownership of the licensed IP; and each party agrees to indemnify the other for breaches caused by its own conduct.

Common mistake: Licensor giving a blanket warranty of non-infringement without a knowledge qualifier. An unqualified IP warranty exposes the licensor to liability for third-party patent claims it had no way to anticipate.

A manufacturing license agreement is a legally binding contract in which an intellectual property owner (the licensor) grants a manufacturer (the licensee) the right to produce goods using the licensor's patents, trade secrets, designs, or trademarks. It defines the territory, exclusivity, royalty structure, quality standards, and termination conditions — giving the licensor ongoing control over how its IP is used in production while allowing the licensee to manufacture and sell the licensed products.

A contract manufacturing agreement engages a third-party manufacturer to produce goods on behalf of the IP owner, typically as a work-for-hire arrangement — the manufacturer charges a production fee and has no independent right to use the IP. A manufacturing license agreement grants the manufacturer independent rights to produce and often to sell the licensed product, with royalties flowing back to the IP owner. Use a contract manufacturing agreement when you want full control and ownership of output; use a manufacturing license when you want to grant the manufacturer a degree of commercial independence.

In the US, recording a patent license with the USPTO is not mandatory but is strongly recommended for exclusive licenses — it provides constructive notice that protects the licensee against a subsequent conflicting license. In some countries, including Germany, China, and several other jurisdictions, recording a patent or trademark license is required for the license to be enforceable against third parties. Consider consulting local counsel in each jurisdiction where the licensed manufacturing will occur.

Manufacturing license royalty rates vary widely by industry, IP type, and exclusivity. Consumer goods patents typically attract royalties of 2–8% of net sales. Pharmaceutical and chemical patents can run 5–15%. Technology and software-embedded manufacturing licenses often use a per-unit fee rather than a percentage. The exclusive premium — the additional rate charged for granting sole manufacturing rights — is commonly 1.5–2× the non-exclusive rate. Minimum royalties should be negotiated alongside the rate.

Not without explicit permission. A standard manufacturing license agreement prohibits sublicensing without the licensor's prior written consent. Allowing sublicensing without controls creates a chain of manufacturers the licensor cannot audit or hold accountable for quality. If the licensee needs to engage subcontractors, include a specific "have manufactured" right in the grant clause rather than a general sublicensing permission.

Quality control should cover three stages: pre-production approval of specifications and materials, production sample approval before each new run, and post-production inspection and audit rights. Specifications should be attached as a schedule rather than embedded in the body of the agreement so they can be updated without amending the main contract. Non-conforming goods should require remediation or destruction within a defined period, and the licensor should retain the right to terminate for persistent quality failures.

On termination, the licensee's right to manufacture ends immediately unless the agreement includes a wind-down period. A 60–90 day sell-off period for finished goods inventory is common, with royalties payable on those final sales. The licensee is typically required to destroy or return any remaining work-in-progress and all confidential materials. Tooling and molds paid for by the licensor should revert to the licensor; those paid for by the licensee are a negotiated point.

Ownership of improvements developed by the licensee defaults to the licensee under patent law in most jurisdictions unless the agreement provides otherwise. A well-drafted improvements clause typically specifies that the licensor owns improvements to the core licensed IP, that the licensee owns process improvements unrelated to the core IP, and that each party grants the other a non-exclusive, royalty-free license-back to improvements it does not own. This balance protects the licensor's foundational IP while giving the licensee incentive to invest in production efficiency.

A complete termination clause addresses: the initial term and auto-renewal notice period; termination for material breach with a 30-day cure period; immediate termination triggers such as insolvency, change of control, or failure to meet minimum royalties; post-termination wind-down provisions for existing inventory; and survival of confidentiality, audit, and IP ownership clauses after expiration. Missing any of these leaves gaps that can result in a licensee continuing to manufacture after termination or a licensor losing access to royalty records the moment the agreement ends.

For straightforward domestic manufacturing licenses involving modest royalty volumes and a trusted counterparty, a high-quality template is a reasonable starting point. Legal review is strongly recommended when the deal is exclusive, the territory spans multiple countries, annual royalties exceed $50,000, the licensed IP includes trade secrets, or enforceability in a specific jurisdiction is critical. A 2–4 hour attorney review typically costs $600–$1,500 and is worthwhile given the long-term financial and IP protection stakes of most manufacturing license arrangements.